Promab Biotechnologies, Inc.
Records under this name other than the patents Promab Biotechnologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Back to Promab Biotechnologies, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,086,055 | Adherent cancer cell line expressing a hematological tumor antigen Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,725,053 | Chimeric antigen receptors comprising a human transferrin epitope sequence Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,927,182 | Humanized Bcma Antibody and Bcma-Car-T Cells Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,021,542 | Humanized Bcma Antibody and Bcma-Car-T Cells Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,142,583 | Bcma-Car-Natural Killer (NK) Cells and Methods Related Thereto Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,299,549 | Humanized Bcma Antibody and Bcma-Car-T Cells Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,472,884 | Humanized Bcma Antibody and Bcma-Car-T Cells Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,435,152 | Humanized BCMA antibody and BCMA-CAR-T cells Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,932,703 | ANTI-ROR1 Antibody and ROR1-TARGETING Engineered Cells Formerly held In force · High confidence | In force | High confidence | |
| US 12,492,264 | ANTI-ROR1 Antibody and ROR1-TARGETING Engineered Cells Formerly held In force · Low confidence | In force | Low confidence |